Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Hironori Nakagami

Prof.

Osaka University

Japan

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

60%

Virology

20%

Anti-aging Research

30%

Covid-19

30%

Inflammatory Biology

20%

Sars-cov-2

20%

Proteostasis

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Acquisition of Humoral Immune Responses in Convalescent Japanese People with SARS-CoV-2 (COVID-19) Infection in 2021

Article Link

Year:

2023

R-spondin 3/LGR4 (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 4) Axis Is a Novel Inflammatory and Neurite Outgrowth Signaling System in the Ischemic Brain in Mice

Article Link

Year:

2023

Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo‐controlled, double‐blind study

Article Link

Year:

2023

Novel pathophysiological roles of α‐synuclein in age‐related vascular endothelial dysfunction

Article Link

Year:

2022

Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults

Article Link

Year:

2022

RANKL Impairs the TLR4 Pathway by Increasing TRAF6 and RANK Interaction in Macrophages

Article Link

Year:

2022

Prevention of vascular dementia via immunotherapeutic blockade of renin-angiotensin system in a rat model

Article Link

Year:

2021

Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia

Article Link

Year:

2021

Development of COVID-19 vaccines utilizing gene therapy technology

Article Link

Year:

2021

Prevention of Acute Lung Injury by a Novel CD14-Inhibitory Receptor Activator of the NF-κB Ligand Peptide in Mice

Article Link

Year:

2021

Collaborators9

MICHIO SATO

Kumamoto University

JAPAN

tsutomu sasaki

Osaka University

JAPAN

Shota Yoshida

Osaka University

JAPAN

Hiroki Hayashi

Osaka University

JAPAN

Kento Asano

Specially Appointed Associate Professor

Osaka University Hospital

JAPAN

Ryo Nakamaru

University of Tokyo

JAPAN

Keishi Miyata

Kumamoto University

JAPAN

Hiromi Rakugi

JAPAN

Hideki Mochizuki

Professor

Osaka University

JAPAN

How do I reach out?

Meet Kite AI